These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32175921)

  • 41. The role of exosomal miR-181b in the crosstalk between NSCLC cells and tumor-associated macrophages.
    Ma J; Chen S; Liu Y; Han H; Gong M; Song Y
    Genes Genomics; 2022 Oct; 44(10):1243-1258. PubMed ID: 35150402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blockade of DC-SIGN
    Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
    Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.
    Hu Z; Sui Q; Jin X; Shan G; Huang Y; Yi Y; Zeng D; Zhao M; Zhan C; Wang Q; Lin Z; Lu T; Chen Z
    J Exp Clin Cancer Res; 2024 Feb; 43(1):63. PubMed ID: 38424624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.
    Zhang C; Wei S; Dai S; Li X; Wang H; Zhang H; Sun G; Shan B; Zhao L
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcription factor c-Maf-targeted cancer immunotherapy.
    Wang Y; Qiu F; Yan J
    Trends Cancer; 2023 Apr; 9(4):265-269. PubMed ID: 36564282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.
    Szulc-Kielbik I; Kielbik M
    Exp Suppl; 2022; 113():107-140. PubMed ID: 35165862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
    Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression.
    Wang L; Hu YY; Zhao JL; Huang F; Liang SQ; Dong L; Chen Y; Yu HC; Bai J; Yang JM; Fan JY; Feng L; Li SZ; Han H; Qin HY
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment.
    Malekghasemi S; Majidi J; Baghbanzadeh A; Abdolalizadeh J; Baradaran B; Aghebati-Maleki L
    Adv Pharm Bull; 2020 Sep; 10(4):556-565. PubMed ID: 33062602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
    Zhang J; Li H; Wu Q; Chen Y; Deng Y; Yang Z; Zhang L; Liu B
    Redox Biol; 2019 Apr; 22():101116. PubMed ID: 30769285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Influencing Factors and Significance of Tumor-associated Macrophage Polarization 
in Tumor Microenvironment].
    Ge W; Wu W
    Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):228-237. PubMed ID: 37035885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-Associated Macrophages as Target for Antitumor Therapy.
    Sawa-Wejksza K; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
    Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
    Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SLC3A2 promotes tumor-associated macrophage polarization through metabolic reprogramming in lung cancer.
    Li Z; Chen S; He X; Gong S; Sun L; Weng L
    Cancer Sci; 2023 Jun; 114(6):2306-2317. PubMed ID: 36793241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor-associated macrophages: implications in cancer immunotherapy.
    Petty AJ; Yang Y
    Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. M1
    Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual-targeting tumor cells and tumor associated macrophages with lipid coated calcium zoledronate for enhanced lung cancer chemoimmunotherapy.
    Zang X; Zhou J; Zhang X; Chen D; Han Y; Chen X
    Int J Pharm; 2021 Feb; 594():120174. PubMed ID: 33338567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.